ARNT was one of the 20 pathways consistently corresponded to up-regulated transcripts and was reported to be involved in the multidrug resistance development of multiple malignant tumors[43], including multiple myeloma[44], and AML (acute myeloid leukemia)[45]. This evidence concerns the gene ARNT and plasma cell myeloma.